Cargando…

Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a)

OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is a common inherited condition associated with cardiovascular disease. This study investigated whether cascade testing for Lp(a) was effective in detecting new cases of elevated Lp(a) in families. METHODS: Relatives from adult probands with Lp(a) concentra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Anindita, Chan, Dick C., Ellis, Katrina L., Pang, Jing, Barnett, Wendy, Woodward, Ann Marie, Vorster, Mary, Norman, Richard, Moses, Eric K., Watts, Gerald F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062205/ https://www.ncbi.nlm.nih.gov/pubmed/35517871 http://dx.doi.org/10.1016/j.ajpc.2022.100343

Ejemplares similares

Effectiveness of proprotein convertase subtilisin/kexin‐9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic
por: Chakraborty, Anindita, et al.
Publicado: (2021)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Overweight in family members of probands with ADHD
por: Geuijen, Pauline M., et al.
Publicado: (2019)

Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial Infarction
por: Sankhesara, Dipen M., et al.
Publicado: (2023)

Long-term fasting improves lipoprotein-associated atherogenic risk in humans
por: Grundler, Franziska, et al.
Publicado: (2021)

Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome
por: Chan, Dick C., et al.
Publicado: (2009)

The relationship between insulin resistance and ion mobility lipoprotein fractions
por: Rowland, Charles M., et al.
Publicado: (2022)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Chan, Dick C., et al.
Publicado: (2019)

RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study
por: Watts, Gerald F., et al.
Publicado: (2023)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
por: Julius, Ulrich
Publicado: (2016)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
por: Schmidlen, Tara J., et al.
Publicado: (2022)

New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects
por: Ying, Qidi, et al.
Publicado: (2021)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities
por: Watts, Gerald F
Publicado: (2001)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
por: Cai, Gaojun, et al.
Publicado: (2019)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
por: Hu, Xingdi, et al.
Publicado: (2023)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Elevated Homocysteine Intensify the Effect of Lipoprotein(a) on Stroke Recurrence
por: Feng, Zhiyuan, et al.
Publicado: (2022)

Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

Lipoprotein (a): Recent Updates on a Unique Lipoprotein
por: Saeed, Anum, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

SAT-572 Extremely Elevated Plasma Lipoprotein X Level Secondary to Alcoholic Cholestasis
por: Nelson, Carolyn Ann, et al.
Publicado: (2020)

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study
por: Afshar, Mehdi, et al.
Publicado: (2020)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
por: van den Berg, Eline H., et al.
Publicado: (2022)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Lipoprotein(a)
por: Reuser, Annika, et al.
Publicado: (2022)

The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis
por: Lin, Tong, et al.
Publicado: (2020)

Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
por: Reyes-Soffer, Gissette, et al.
Publicado: (2021)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
por: Chan, Dick C., et al.
Publicado: (2018)

Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way
por: Schlüter, Klaus-Dieter, et al.
Publicado: (2017)

Elevation of Oxidized Lipoprotein of Low Density in Users of Combined Oral Contraceptives
por: dos Santos, Alan Carlos Nery, et al.
Publicado: (2018)

Acute Pulmonary Embolism in a Healthy Male With Elevated Lipoprotein(a)
por: Samal, Subhankar, et al.
Publicado: (2020)

Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies
por: Handhle, Ahmed, et al.
Publicado: (2021)

Elevated Lipoprotein(a) and Cerebral Venous Sinus Thrombosis in COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vi9j4jla5ojap55fq36a9jj3ik